RecallRadar

FDA Device recall Z-2249-2013

ACL TOP 300 and ACL TOP 300 CTS (Japan)

On 2013-09-25 the FDA classified a Class II recall of ACL TOP 300 and ACL TOP 300 CTS (Japan) by Instrumentation Laboratory, citing potential carryover issue that can can cause shortened APTT clotting times on the instrument.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-2249-2013
ClassificationClass II
Statusterminated
Initiated2013-07-19
Published2013-09-25
Last updated2026-09-13 11:53 UTC
CompanyInstrumentation Laboratory
DistributionAL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV

Product

ACL TOP 300 and ACL TOP 300 CTS (Japan); PN 0000280060 Bench top, fully automated, random access analyzer designed specifically for in vitro diagnostic clinical use in the hemostasis laboratory for coagulation and/or fibrinolysis testing in the assessment of thrombosis and/or hemostasis. The systems provide results for both direct hemostasis measurements and calculated parameters.

Reason

Potential carryover issue that can can cause shortened APTT clotting times on the instrument.

Identifiers

code_infoStart SN and Date: 12060256, Jun 2012; End SN and Date: 13070837, July 2013 and Start SN and Date: 11120131J, Dec 2011; End SN and Date: 13060320J, Jun2013

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2249-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.